Assyro AI

FDA Orange Book · active-ingredient family

Chlorothiazide sodium

Chlorothiazide sodium is approved as 1 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DIURIL · NDA 011145

1

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
DIURILRLDRISINGNDA 011145Approved Prior to Jan 1, 1982

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
CHLOROTHIAZIDE SODIUMGLANDANDA 218630APOct 03, 2024
CHLOROTHIAZIDE SODIUMSAGENT PHARMS INCANDA 202462APMay 29, 2015
CHLOROTHIAZIDE SODIUMRK PHARMAANDA 202493Jun 18, 2014
CHLOROTHIAZIDE SODIUMAM REGENTANDA 202561APApr 22, 2013
CHLOROTHIAZIDE SODIUMSUN PHARMANDA 091546APJul 26, 2011
CHLOROTHIAZIDE SODIUMFRESENIUS KABI USAANDA 090896APOct 16, 2009

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Chlorothiazide sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.